VBS announced the award of a $1.2 million, milestone-based, 3-year contract from the National Heart Lung Blood Institute (NHLBI) of the National Institutes of Health (NIH) to expedite the development of CAR therapeutic peptide pulmonary hypertension

Vascular BioSciences (VBS) announces it will be presenting at a National Heart Lung and Blood Institute (NHLBI) conference on June 11, 2013, from 10:30 to 5pm at the Janssen Research & Development Labs, 3210 Merryfield Row, San Diego CA 92130.